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Hepatectomy in Children 
Shunzaburo Iwatsuki, MD and Thomas E. Starzl, MD, PhD 
Tumors of the liver in infants and children are uncommon. A committee of the Sur-
gical Section of the American Academy of Pediatrics surveyed liver tumors in chil-
dren who were operated upon during the 10 years preceding 1974. They collected only 
375 liver tumors of which 252 were malignant and 123 benign [1]. The most common 
malignant tumor was hepatoblastoma followed closely by hepatocellular carcinoma. 
Complete excision of the tumor was achieved in a little less than a half of the children 
with hepatoblastoma or hepatocellular carcinoma [l]. 
Because of the infrequency with which partial hepatic resections are done, there are 
few pediatric surgeons who are experienced with such operations. However, in the 
personal series of 129 subtotal hepatectomies compiled by us since 1963, there have 
been 14 patients in the pediatric age group. The treatment in these 14 cases will be dis-
cussed. 
In addition, eight children with primary malignant liver tumors were treated by 
total hepatectomy and liver replacement (orthotopic liver transplantation) during the 
same period. This latter experience has shown that cure of a liver tumor is a possibility 
after transplantation. 
SUBTOTAL HEPATECTOMY 
Technical Considerations 
The four kinds of liver resection commonly used are shown in Figure 1. They con-
sist of true right lobectomy, true left lobectomy, excision of the lateral segment of the 
left lobe, and right trisegmentectomy. With a right trisegmentectomy, the true right 
lobe is removed in continuity with the medial segment of the left lobe. The surgical 
techniques have been described by which these procedures can be performed safely 
[2, 3]. 
A fifth resection may be applicable, namely left trisegmentectomy. With this opera-
tion, the true left lobe is removed, in continuity with the anterior segment of the right 
lobe. We have performed such an operation four times with success on each occasion. 
One patient was a lO-year-old boy (Fig. 2). To our knowledge, these are the only 
examples of this radical operation being performed in humans. The patient shown in 
Figure 2 is free of disease after 12 months. 
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Fig. 1. Conventional hepatic resections. 
Case Material 
Fourteen children were treated with subtotal hepatectomy (Table I). Six were male 
and eight female. The age ranged from 11 months to 16 years. Ten children had pri-
mary malignant liver tumors; one hepatoblastoma, six hepatocellular carcinomas, 
and three sarcomas. Two children had metastatic liver tumors, one from a neuroblas-
toma of the right adrenal gland and another from a Wilms' tumor of the kidney. One 
child had an adenoma. One child had a liver resection for trauma. Follow-ups here 
have been for 1 to 15 years (Table I). 
There were nine right trisegmentectomies, one left trisegmentectomy, one right 
lobectomy, two left lobectomies, and one nonanatomical resection of the liver 
(Table I). There were no operative deaths nor any serious complications such as 
bleeding, subphrenic abscess formation, or bile duct injury. The earliest death after 
hepatic resection occurred 6 months after a left hepatic lobectomy, due to the recur-
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Fig. 2. A child with a large hepatoma dominant in the true left lobe could not be treated by con -
ventional left lobectomy. A left trisegmentectomy was carried out along the line. 
renee of hepatoblastoma (Table 1). Minor bile leaks through the drain site were 
common, but these were all closed spontaneously. 
Adjuvant Therapy 
Eleven of the 12 patients with malignant disease received chemotherapy after 
hepatic resection, and four were given radiation therapy (Table I). One patient had 
chemotherapy before, but not after resection . 
The agents used for chemotherapy were variable and were influenced by the histo-
pathology (Table II). Initially, the most common treatment for hepatomas and 
hepatoblastomas was cyclophosphamide, 5-fluorourcil, and vincristine, as described 
by Holton and co-workers [4]. This was followed with adriamycin, if necessary, for 
recurrences . Later, those four agents were begun simultaneously as soon as the 
children recovered from the surgical procedure. The time after surgery usually ranged 
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TABLE II. Adjuvant Chemotherapy 
Case No. 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Diagnosis 
Hepatoblastoma 
Hepatocellular ca 
Hepatocellular ca 
Hepatocellular ca 
Hepatocellular ca 
Hepatocellular ca 
Hepatocellular ca 
Sarcoma 
Rhabdomyosarcoma 
Sarcoma (?) 
Neuroblastoma 
Wilm's tumor 
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Chemotherapy agents 
Cytoxan, vincristine, 5-FU 
Cytoxan, vincristine, 5-FU 
Cytoxan, vincristine, 5-FU 
Cytoxan, vincristine, 5-FU 
Cytoxan, vincristine, 5-FU, Adriamycin 
Cytoxan, vincristine, 5-FU, Adriamycin 
None after resection 
Cytoxan, vincristine, 5-FU 
Vincristine, dactinomycin, cytoxan 
Cytoxan, vincristine, dactinomycin, DTIC, adriamycin 
Cytoxan, vincristine, CCNU, adriamycin 
Dactinomycin, vincristine 
from a few days to several weeks. The heterogeneity of agents, dosage, and timing of 
adjuvant therapeutic protocols and small number of cases precluded conclusions 
about effectiveness beyond the observation that good long-term survival was 
obtained with adjuvant therapeutic treatment, even in some patients who had known 
recurrences. 
Late Results 
Primary hepatic malignant tumor. The results are summarized in Table 1. Nine 
of 10 children survived at least 1 year. Seven of the 10 children are alive with follow-up 
periods of 1 to 7 years, and six of them are free of disease. Another with stable pul-
monary metastasis is under new chemotherapy after 4 years. Three children died with 
disease 6, 17, and 19 months after hepatic resection. Four children are alive and free 
of disease for more than 5 years and are considered to be cured. 
Metastatic malignant tumor. One child with neuroblastoma is alive more than 6 
years after resection and is considered to be cured. Another child with Wilms' tumor 
died with disease after 10 months (Table I). 
Benign disease. These two children recovered completely and have no com-
plaints or hepatic function abnormalities after many years (Table I). 
TOTAL HEPATECTOMY AND LIVER REPLACEMENT (ORTHOTOPIC LIVER 
TRANSPLANTATION) 
Primary liver malignancy which cannot be treated with conventional techniques of 
subtotal hepatectomy could theoretically be cured by total hepatectomy and liver re-
placement. Eight children with primary liver malignancy received orthotopic liver 
transplantation since 1963. 
- ------------------------ ----
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TABI,E 1lI. Eight Children with Primary Liver Malignancy Wbo Were Treated by Total 
Hepatectomy and Liver Replacement (Orthotopic Liver Transplantation) 
Case No. Age 
(yr) Sex 
15. 3 F 
16. 7 F 
17. 5 F 
18. 11 F 
19. 9 F 
20. 17/12 F 
21. 16 F 
22. 15 M 
Case Material 
Diagnosis 
Biliary atresia, 
incidental hepatocellular 
carcinoma 
Biliary atresia, 
incidental hepatocellular 
carcinoma 
Alpha-I-antitrypsin 
deficiency 
incidental hepatoblastoma 
Biliary atresia, 
concomitant hepatocellular 
carcinoma 
Tryosinernia, 
concomitant hepatocellular 
carcinoma 
Hepatocellular carcinoma 
Hepatocellular carcinoma 
Hepatocellular carcinoma 
Survival 
Alive 12 years 
without disease 
Operative death 
Alive 3 years 
without disease 
Died 3 months 
with disease 
Died 3 months 
with disease 
Died 14 months 
with disease 
Died 15 months 
with disease 
Died 5 months 
with disease 
Three children received liver transplantation for end-stage liver disease. In the 
excised livers were found incidental primary liver malignancies (Table Ill). 
Two other children had end-stage liver disease and concomitant primary liver 
malignancy which was known prior to transplantation (Table Ill). The three final 
children had primary liver malignancy which was not resectable by conventional tech-
nique of subtotal hepatectomy (Table III). Transplantation was decided upon as a 
means of extending the limit of resection. 
There were seven hepatocellular carcinomas and one hepatoblastoma. The age 
ranged between 1 year and 7 months old to 16 years old. 
Surgical and Medical Therapy 
The surgical techniques of orthotopic liver transplantation have been described 
elsewhere [5]. The new liver was placed in the anatomical position. 
For immunosuppression, these eight patients were given azathioprine, prednisone, 
and horse antilymphocyte globulin. 
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TABLE IV. Tumors or Tumor-like Lesions of the Liver in Infants and Children 
Malignant group 
I. Liver cell carcinoma 
Hepatoblastoma 
Hepatocellular carcinoma 
2. Hepatic mixed tumors 
3. Mesenchymoma (malignant) 
4. Sarcoma 
5. Metastatic tumor 
Benign group 
I. Tumor-like epithelial lesions 
Focal nodular hyperplasia 
Multiple nodular hyperplasia 
Accessary lobe 
2. Benign eipithelial tumors 
Adenoma 
Adrenal rest tumor 
3. Cysts and tumor-like mesenchymal tumor 
Mesenchymal hamartoma 
Nonparasitic cyst 
4. Benign mesenchymal tumors 
Cavernous hemangioma 
Infantile hemangioendotheliomas 
5. Teratoma 
Survival 
There was one operative death (12.5070 operative mortality). Five children died with 
recurrent tumor between 3 and 15 months after transplant, after a mean survival of 8 
months (Table III). These five children all had advanced stages of liver malignancy 
with bulky tumors. Two children are alive and free of disease 3 years and 12 years, re-
spectively, after transplant. In both children, primary liver malignancy was discov-
ered at the pathological examination of the removed organ (Table III), and thus the 
tumors were incidental findings. 
COMMENT 
Edmondson [6], classified liver neoplasms in his classic paper in 1956 (Table IV). In 
the 1974 survey of the American Academy of Pediatrics [1], the ratio of malignant to 
benign lesions was 2 to 1. Among the benign lesions hemangioma, hamartoma, 
epithelioma, benign cyst, and adenoma were the most common in that order of fre-
quency. Ninety percent of the malignant tumors were hepatoblastomas or hepato-
cellular carcinomas. Hepatoblastoma occurred largely in the infant population; 
almost half the patients were 18 months of age or younger. In the patients with 
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hepatocellular carcinoma, there appeared to be two age peaks, one in the age below 4 
years, and another in age between 12 and 15 years. 
An unacceptably high (20-300,70) operative mortality from hepatic resection has 
been reported in the literature. Ishak and Glunz [7], reported that 4 of the 18 patients 
with hepatoblastoma or hepatocellular carcinoma died on the operating table during 
hepatic resection. The survey by the American Academy of Pediatrics, Surgical 
Section, also reported that 25 of 223 patients with hepatoblastoma or hepatocellular 
carcinoma who had exploratory celiotomy died on the operating table or in the imme-
diate postoperative period. Since definitive resections were carried out in less than 
half the cases, the operative mortality from resection apparently exceeded 200,70. At an 
earlier time at the Boston Children's Hospital there was an 180,70 operative mortality 
[8], and at the Hospital for Sick Children in London, the death rate was 310,70 [9]. 
Major hepatic resections can now be done quite safely. In our 14 hepatic resections, 
there was no operative mortality. The earliest death occurred 6 months after opera-
tion due to recurrence of tumor. The authors' personal series of 129 major hepatic re-
sections were carried out with the operative mortality of only 30,70 during the last 18 
years. Wilson, Adson, and Weiland from Mayo Clinic also reported the operative 
mortality of less than 50,70 [10, 11]. Thus, major hepatic resection has become a safe 
operative procedure at places where hepatic operations are performed rather 
frequently. 
Surgical resection offers the only chance of survival for patients with malignant 
hepatic neoplasms. Ishak and Glunz [7] reported that none of the children who did 
not have the benefit of surgical resection survived more than 1 year, but that 9 of the 
11 children whose tumors were resected were alive; 6 of these 9 children had survived 
for 4,5,6,8,9, and 13 years, respectively, without evidence of recurrence. The survey 
by the American Academy of Pediatrics [1] also reported that there were no survivors 
at 2 years after biopsy only or incomplete resection of tumors, but that 600,70 of the 
children with hepatoblastoma and 350,70 of them with hepatocellular carcinoma sur-
vived. The prognosis of hepatocellular carcinoma has been said to be poorer than that 
of he pat obi as tom a [1,7,12]. In our present series 7 ofthe 10 children who had cura-
tive hepatic resections for primary hepatic malignancy are alive for 1 to 7 years includ-
ing 4 of 6 with hepatomas and 3 of 3 with sarcomas. 
The role of adjuvant chemotherapy and radiation therapy has been questioned for 
a long time [1, 7]. The lack of significant numbers of cases has precluded a meaningful 
conclusion. However, our satisfactory long-term results of hepatic resection with 
adjuvant therapy have been noted and defended elsewhere [3]. 
The limits of resectability can be extended by treating primary liver malignancy 
with total hepatectomy and orthotopic liver transplantation. However, a high recur-
rence rate of the original malignancy after successful transplantation has dampened 
enthusiasm for this approach. Nevertheless, a small but significant palliation has been 
achieved with this approach, even in some patients who eventually have died of recur-
rence [13-15]. Further gains will be possible only with extremely discriminating selec-
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tion of prospective recipients and better immunosuppressive therapy. Effective 
adjuvant therapy to prevent recurrence is awaited. 
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